Nishadil
Signup Signin
Delhi | 25°C (windy)
Beyond the Buzz: Unpacking Digital Media's Big Players Amidst Market Swirls

Beyond the Buzz: Unpacking Digital Media's Big Players Amidst Market Swirls
Navigating the Currents: A Deep Dive into HealthEquity and Auna's Market Tales

Navigating the Currents: A Deep Dive into HealthEquity and Auna's Market Tales
The Quiet Confidence: Why One Investment Firm Is Deepening Its Bet on Alphabet

The Quiet Confidence: Why One Investment Firm Is Deepening Its Bet on Alphabet
The Unyielding Gravitational Pull: Why Smart Money Keeps Doubling Down on Alphabet

The Unyielding Gravitational Pull: Why Smart Money Keeps Doubling Down on Alphabet
Navigating the Daily Tempest: What Really Moves the Market (And Our Moods)

Navigating the Daily Tempest: What Really Moves the Market (And Our Moods)
The Unlikely Showdown: Weighing Your Bets on Cannabis vs. the Enigma of Hybrid Energy

The Unlikely Showdown: Weighing Your Bets on Cannabis vs. the Enigma of Hybrid Energy
The Bitcoin Enigma: Can the King of Crypto Really Touch Six Figures?

The Bitcoin Enigma: Can the King of Crypto Really Touch Six Figures?
The Market's Morning Murmur: A Cautious Ascent Amidst Unseen Forces

The Market's Morning Murmur: A Cautious Ascent Amidst Unseen Forces
The Week Blast Trading Hit a Wall: A Deep Dive into a Staggering 10.2% Drop

The Week Blast Trading Hit a Wall: A Deep Dive into a Staggering 10.2% Drop
Beyond the Noise: Unpacking TCW's Relative Value Approach for Q3 2025—And What It Means for Your Portfolio

Beyond the Noise: Unpacking TCW's Relative Value Approach for Q3 2025—And What It Means for Your Portfolio
The Great Semiconductor Shuffle: Why Smart Money is Still Betting on Intel

The Great Semiconductor Shuffle: Why Smart Money is Still Betting on Intel
The Qoria Crossroads: Unpacking Jane Watts's Monumental Stock Divestment

The Qoria Crossroads: Unpacking Jane Watts's Monumental Stock Divestment
The Shifting Sands: Colleen Tupper's Bold Move with Collegium Pharmaceutical Stock

The Shifting Sands: Colleen Tupper's Bold Move with Collegium Pharmaceutical Stock
A Vote of Confidence: Why Envestnet is Betting Big on Intapp's Future

A Vote of Confidence: Why Envestnet is Betting Big on Intapp's Future
The Hunt for Tomorrow's Titans: Five Altcoins Under $5 Poised to Explode?

The Hunt for Tomorrow's Titans: Five Altcoins Under $5 Poised to Explode?
The Wild Ride of Trump Media: Why DJT's Stock Just Took Another Nosedive

The Wild Ride of Trump Media: Why DJT's Stock Just Took Another Nosedive
The Numbers Are In: Unpacking EOG Resources' Latest Financial Saga

The Numbers Are In: Unpacking EOG Resources' Latest Financial Saga
The Jolt and Jitter: Unpacking Blink Charging's Q3 Performance in a Dynamic EV Landscape

The Jolt and Jitter: Unpacking Blink Charging's Q3 Performance in a Dynamic EV Landscape
A Whisper Turns into a Roar: Unpacking Melrose Industries' Sudden Market Ascent

A Whisper Turns into a Roar: Unpacking Melrose Industries' Sudden Market Ascent
The Market's Winding Road: Tech Trembles, Trump Surges, and Dollar Tree Does a Double Take

The Market's Winding Road: Tech Trembles, Trump Surges, and Dollar Tree Does a Double Take
The Next Big Thing? Chasing Crypto's Fading Stars and Emerging Hopes

The Next Big Thing? Chasing Crypto's Fading Stars and Emerging Hopes
AMD's Moment in the Sun? Why Analysts Are Looking Up at the Chip Giant

AMD's Moment in the Sun? Why Analysts Are Looking Up at the Chip Giant
The Great Rebound: Why Wall Street's Whispers Point to Expedia's Ascent

The Great Rebound: Why Wall Street's Whispers Point to Expedia's Ascent
The Quiet Confidence: A Major Bank's Multi-Million Dollar Bet on Tesla

The Quiet Confidence: A Major Bank's Multi-Million Dollar Bet on Tesla
The Market's Murmur: A Mid-Morning Pause in the Great Ascent?

The Market's Murmur: A Mid-Morning Pause in the Great Ascent?
The Quiet Confidence: Why Van Cleef Sees Enduring Value in UnitedHealth's Massive Reach

The Quiet Confidence: Why Van Cleef Sees Enduring Value in UnitedHealth's Massive Reach
A Clash of Healthcare Titans: Peering into the Futures of Veracyte and Fresenius

A Clash of Healthcare Titans: Peering into the Futures of Veracyte and Fresenius
The Quiet Confidence: Why a Japanese Giant Just Deepened Its Bet on Verizon

The Quiet Confidence: Why a Japanese Giant Just Deepened Its Bet on Verizon
A Giant Leap of Faith? Why This Investment Firm Just Bet Big on Sun Life

A Giant Leap of Faith? Why This Investment Firm Just Bet Big on Sun Life
The Shifting Tides: Why Zacks Just Tapped the Brakes on NAPCO Security's Stock

The Shifting Tides: Why Zacks Just Tapped the Brakes on NAPCO Security's Stock
The Great Reckoning: Why One Chart Might Just Change How You See the S&P 500's Future

The Great Reckoning: Why One Chart Might Just Change How You See the S&P 500's Future
Beyond the Bluster: Five Unexpected Stocks Bank of America Believes Still Hold Untapped Power

Beyond the Bluster: Five Unexpected Stocks Bank of America Believes Still Hold Untapped Power
A Quiet Bet on a Legacy Player: Why Sigma Planning Just Went Deeper into Pitney Bowes

A Quiet Bet on a Legacy Player: Why Sigma Planning Just Went Deeper into Pitney Bowes
The Whisper of an Exit: What Jack Kaye's uniQure Stock Sale Could Tell Us

The Whisper of an Exit: What Jack Kaye's uniQure Stock Sale Could Tell Us
The Shifting Sands? TKO Group Director Offloads Millions in Stock, Raising Eyebrows

The Shifting Sands? TKO Group Director Offloads Millions in Stock, Raising Eyebrows
The CEO's Gambit: Decoding Julie Sweet's Accenture Stock Sale

The CEO's Gambit: Decoding Julie Sweet's Accenture Stock Sale
The Future Looks Brighter: Ouster Scores a Major Vote of Confidence from Wall Street

The Future Looks Brighter: Ouster Scores a Major Vote of Confidence from Wall Street
The Ascent of V2X: Analysts Eye a Brighter Horizon for the Defense Contractor

The Ascent of V2X: Analysts Eye a Brighter Horizon for the Defense Contractor
Market Watch: Goldman Sachs Takes a Fresh Look at Gartner’s Horizon

Market Watch: Goldman Sachs Takes a Fresh Look at Gartner’s Horizon
Nektar Therapeutics: A Whisper of Change on Wall Street?

Nektar Therapeutics: A Whisper of Change on Wall Street?
A Second Look? Wall Street Zen Shifts Stance on ECARX, Moving to a 'Hold'

A Second Look? Wall Street Zen Shifts Stance on ECARX, Moving to a 'Hold'
A Shift in the Tides: Wall Street Zen Takes a More Measured View of American Coastal Insurance

A Shift in the Tides: Wall Street Zen Takes a More Measured View of American Coastal Insurance
ITV's Quiet Climb: Is the Broadcaster Finally Back in the Spotlight?

ITV's Quiet Climb: Is the Broadcaster Finally Back in the Spotlight?
Load more..